Everolimus in combination with T-DM1 showed strong antitumor effects in HER2-positive breast cancer, both in vitro and in vivo.
[Molecular Cancer Research]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Mammary Cell News mTOR Inhibition and Trastuzumab-Emtansine (T-DM1) in HER2-Positive Breast Cancer
